Podcast Episodes
Back to SearchPharmaceutical Executive Daily: Roche Reports Positive Phase II Study Results for Dual GLP-1/GIP Receptor Agonist
In today’s pharmaceutical executive daily, Roche reports positive Phase II results for a dual GLP-1/GIP receptor agonist, procurement leaders reasses…
5 months, 2 weeks ago
Pharmaceutical Executive Daily: Mirum Pharmaceuticals Acquires Bluejay Therapeutics
In todays pharmaceutical executive daily, Mirum Pharmaceuticals strengthens its rare disease portfolio through a $268 million acquisition, industry e…
5 months, 2 weeks ago
Pharmaceutical Executive Daily: Tariff Uncertainty Accelerates Manufacturing Shifts
In today’s Pharmaceutical Executive Daily, tariff uncertainty triggers a short-term surge in pharmaceutical manufacturing activity, workforce burnout…
5 months, 2 weeks ago
Pharmaceutical Executive Daily: United States' Set to Exit WHO
In today’s Pharmaceutical Executive Daily, the World Health Organization finalizes the United States’ withdrawal from the global health body, Bristol…
5 months, 3 weeks ago
Pharmaceutical Executive Daily: New Study Finds No Evidence Linking Tylenol Use to Autism Risk
In today’s Pharmaceutical Executive Daily, a new study reignites debate over a potential link between Tylenol use and autism risk, TopGum signs a $12…
5 months, 3 weeks ago
Pharmaceutical Executive Daily: GSK's $2 Billion Acquisition of RAPT Therapeutics
In today’s Pharmaceutical Executive Daily, GSK moves to strengthen its immunology pipeline with a $2 billion acquisition of RAPT Therapeutics, Atkins…
5 months, 3 weeks ago
Pharmaceutical Executive Daily: Henlius' Exclusive License Agreement with U-Mab Biopharma
In today’s Pharmaceutical Executive Daily, Henlius enters a global exclusive licensing agreement with UMAb Biopharma for a potential best-in-class an…
5 months, 3 weeks ago
Pharmaceutical Executive Daily: President Trump's Great Healthcare Plan
In today’s Pharmaceutical Executive Daily, Johnson & Johnson announces plans for a second $2 billion manufacturing facility in North Carolina, Presid…
5 months, 3 weeks ago
Pharmaceutical Executive Daily: Continued Coverage of the 2026 J.P. Morgan Healthcare Conference
In today’s Pharmaceutical Executive Daily we will focus on the 44th Annual J.P. Morgan Healthcare Conference, with Genmab outlining a disciplined str…
5 months, 4 weeks ago
Pharmaceutical Executive Daily: 2026 J.P. Morgan Healthcare Conference Coverage
In today’s Pharmaceutical Executive Daily we will focus on the 44th Annual J.P. Morgan Healthcare Conference, with Biogen outlining how a more focuse…
5 months, 4 weeks ago